Senti Biosciences Stock Probability of Future Stock Price Finishing Under 0.14
| SNTI Stock | USD 2.17 0.05 2.36% |
Senti |
Senti Biosciences Target Price Odds to finish below 0.14
The tendency of Senti Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.14 or more in 90 days |
| 2.17 | 90 days | 0.14 | near 1 |
Based on a normal probability distribution, the odds of Senti Biosciences to drop to $ 0.14 or more in 90 days from now is near 1 (This Senti Biosciences probability density function shows the probability of Senti Stock to fall within a particular range of prices over 90 days) . Probability of Senti Biosciences price to stay between $ 0.14 and its current price of $2.17 at the end of the 90-day period is about 21.17 .
Given the investment horizon of 90 days Senti Biosciences has a beta of 0.36. This usually implies as returns on the market go up, Senti Biosciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Senti Biosciences will be expected to be much smaller as well. Additionally Senti Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Senti Biosciences Price Density |
| Price |
Predictive Modules for Senti Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Senti Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Senti Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Senti Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Senti Biosciences is not an exception. The market had few large corrections towards the Senti Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Senti Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Senti Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.26 | |
β | Beta against Dow Jones | 0.36 | |
σ | Overall volatility | 0.35 | |
Ir | Information ratio | -0.07 |
Senti Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Senti Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Senti Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Senti Biosciences generated a negative expected return over the last 90 days | |
| Senti Biosciences has high historical volatility and very poor performance | |
| Senti Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 2.56 M. Net Loss for the year was (71.06 M) with loss before overhead, payroll, taxes, and interest of (29.78 M). | |
| Senti Biosciences currently holds about 140.78 M in cash with (52.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Senti Biosciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Senti Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com |
Senti Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Senti Stock often depends not only on the future outlook of the current and potential Senti Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Senti Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.4 M | |
| Cash And Short Term Investments | 35.9 M |
Senti Biosciences Technical Analysis
Senti Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Senti Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Senti Biosciences. In general, you should focus on analyzing Senti Stock price patterns and their correlations with different microeconomic environments and drivers.
Senti Biosciences Predictive Forecast Models
Senti Biosciences' time-series forecasting models is one of many Senti Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Senti Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Senti Biosciences
Checking the ongoing alerts about Senti Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Senti Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Senti Biosciences generated a negative expected return over the last 90 days | |
| Senti Biosciences has high historical volatility and very poor performance | |
| Senti Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 2.56 M. Net Loss for the year was (71.06 M) with loss before overhead, payroll, taxes, and interest of (29.78 M). | |
| Senti Biosciences currently holds about 140.78 M in cash with (52.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Senti Biosciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Senti Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com |
Check out Senti Biosciences Backtesting, Senti Biosciences Valuation, Senti Biosciences Correlation, Senti Biosciences Hype Analysis, Senti Biosciences Volatility, Senti Biosciences History as well as Senti Biosciences Performance. For more detail on how to invest in Senti Stock please use our How to Invest in Senti Biosciences guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Senti Biosciences. If investors know Senti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Senti Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (15.59) | Revenue Per Share 0.075 | Quarterly Revenue Growth (1.00) | Return On Assets (0.33) | Return On Equity (1.11) |
The market value of Senti Biosciences is measured differently than its book value, which is the value of Senti that is recorded on the company's balance sheet. Investors also form their own opinion of Senti Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Senti Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Senti Biosciences' market value can be influenced by many factors that don't directly affect Senti Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Senti Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Senti Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Senti Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.